Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Investment
Features
FeesSafety
Academy
More
Pluang+

Compare abrdn Income Credit Strategies Fund (ACP) vs Cronos Group Inc (CRON) Price & Performance

abrdn Income Credit Strategies Fund
Cronos Group Inc

Price performance

Price movement over the last 24 hours

Key statistics

abrdn Income Credit Strategies Fund vs Cronos Group Inc — how do they compare? abrdn Income Credit Strategies Fund trades at $5.21 (market cap $656.21M), while Cronos Group Inc trades at $2.75 (market cap $1.03B). The key difference: Cronos Group Inc is the larger of the two by market cap, and abrdn Income Credit Strategies Fund pays a 17.78% dividend while Cronos Group Inc pays none. Which is the better fit depends on your goals.

ACPCRON
Market Cap
$656.21M$1.03B
Sector
FinancialsHealth
52-Week High
$5.98$3.27
52-Week Low
$5.01$1.95
Dividend Yield
17.78%
Enterprise Value
$205.93M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

abrdn Income Credit Strategies Fund

ACP trades at $5.25, down 0.57% today, with a neutral technical signal. The stock shows a low P/B of 0.89 and a high net income margin of 95.51% for 2024, though revenue declined from $79M in 2024 to $42M in 2025. Recent news highlights dividend declarations and a Seeking Alpha downgrade citing distribution sustainability concerns. Cash flow from operations was negative $81.31M in 2024, offset by financing inflows.

Outlook is mixed: valuation appears modest with a P/E near 16, but declining revenue and negative operating cash flow pose risks. The 17% distribution rate faces sustainability questions, while technical indicators suggest limited near-term momentum. Investors should weigh income potential against fundamental weaknesses and high beta exposure.

Cronos Group Inc

Cronos Group (CRON) trades at $2.75, down 3.85% on the day, with mixed technical signals showing a bullish moving average trend but neutral oscillators. The company reported Q1 2026 revenue growth of 40% year-over-year to $45.2 million, achieving record net revenue and gross profit. However, net income remains negative at -$9.45 million for 2025, though margins have improved significantly from prior years. Recent news highlights expansion in Canada and Israel, along with a share repurchase program extension.

Outlook is cautiously optimistic with strong revenue growth and market share gains, but profitability challenges and intense cannabis competition pose risks. Analyst sentiment is mixed with 60% hold ratings. Key catalysts include international expansion and execution on cost controls, while regulatory uncertainty and cash flow volatility remain headwinds for investors.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About abrdn Income Credit Strategies Fund

abrdn Income Credit Strategies Fund is a diversified, closed-end investment management company. Its primary goal is to generate high current income, with capital appreciation as a secondary objective. The fund mainly invests in debt and loan instruments from issuers across various industries and regions.

Read more on ACP

About Cronos Group Inc

Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.

Read more on CRON